Therapeutic potential of Lianhua Qingke in airway mucus hypersecretion of acute exacerbation of chronic obstructive pulmonary disease
Abstract Background Lianhua Qingke (LHQK) is an effective traditional Chinese medicine used for treating acute tracheobronchitis. In this study, we evaluated the effectiveness of LHQK in managing airway mucus hypersecretion in the acute exacerbation of chronic obstructive pulmonary disease (AECOPD)....
Saved in:
Main Authors: | Yuanjie Hao (Author), Tongxing Wang (Author), Yunlong Hou (Author), Xiaoqi Wang (Author), Yujie Yin (Author), Yi Liu (Author), Ningxin Han (Author), Yan Ma (Author), Zhen Li (Author), Yaru Wei (Author), Wei Feng (Author), Zhenhua Jia (Author), Hui Qi (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2023-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Azithromycin Inhibits Mucus Hypersecretion from Airway Epithelial Cells
by: Takeshi Shimizu, et al.
Published: (2012) -
Mucus Hypersecretion in Chronic Obstructive Pulmonary Disease and Its Treatment
by: Binay Kumar Shah, et al.
Published: (2023) -
Lobeglitazone Attenuates Airway Inflammation and Mucus Hypersecretion in a Murine Model of Ovalbumin-Induced Asthma
by: Na-Rae Shin, et al.
Published: (2018) -
Cytokine Storm and Mucus Hypersecretion in COVID-19: Review of Mechanisms
by: Khan MA, et al.
Published: (2021) -
PP121, a dual inhibitor of tyrosine and phosphoinositide kinases, relieves airway hyperresponsiveness, mucus hypersecretion and inflammation in a murine asthma model
by: Wei Li, et al.
Published: (2023)